D-0865-2018 Class III Terminated

Recalled by Pharmaceutical Associates Inc — Greenville, SC

FDA drug recall D-0865-2018 was initiated by Pharmaceutical Associates Inc on May 29, 2018 and is designated Class III. Reason for recall: Resuspension problems: Out of specification for appearance and resuspendability. The recall status is terminated (terminated Jan 13, 2020). Affected quantity: 275400 cups.

Recall details

Product Type
Drugs
Report Date
Jun 13, 2018
Initiation Date
May 29, 2018
Termination Date
Jan 13, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
275400 cups

Product description

Nystatin Oral Suspension, USP, 500,000 units/5 mL, For Institutional Use Only, packaged in 5 mL cups, Rx Only, Pharmaceutical Associates, Inc. Greenville, SC 29605, NDC 0121-4810-05

Reason for recall

Resuspension problems: Out of specification for appearance and resuspendability.

Distribution pattern

Nationwide

Code information

Lot: B5B8 Exp. 07/2019

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0865-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0865-2018. Report a data issue: hello@regdatalab.com.